Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › rifapentine

rifapentine

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of rifapentine

3 trials tracked of rifapentine: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 33 citations.

3Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 1 1 Other / NA 1
  1. Phase 3 TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens Completed · 33 cited
  2. Phase 1 Impact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers (YODA) Completed
  3. N/A Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Rifapentine 15 mg/kg and 20 mg/kg yield higher culture conversion than standard 6-month regimen
Infectious Disease RCT
Rifapentine 15 mg/kg and 20 mg/kg yield higher culture conversion than standard 6-month regimen Trial Shows Rifapentine Dosage Impacts Tuberculosis Treatment Outcomes
This Phase 2/3 Stage 1 randomized controlled trial of 400 adults with pulmonary drug-susceptible tuberculosis compared three 4-month rifapen…
A new clinical trial explores how different doses of rifapentine affect treatment success and safety for patients with drug-susceptible tube…
Aug 3, 2026